Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

ClinicalTrials.gov ID: NCT05403827

Public ClinicalTrials.gov record NCT05403827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 4:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Prospective, Double-masked, Randomized, Multi-center, Vehicle-controlled, Parallel-group, 12-week Administration and 40-week Extension Study Confirming the Efficacy and Safety of K-161 Ophthalmic Solution for the Treatment of Moderate to Severe Dry Eye Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy and safety of K-161 ophthalmic solution for the treatment of moderate to severe dry eye disease.

Study identification

NCT ID
NCT05403827
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
644 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2, 2022
Primary completion
Aug 24, 2023
Completion
Dec 4, 2023
Last update posted
Jan 13, 2025

2022 – 2023

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
48
Facility City State ZIP Site status
The University of Alabama at Birmingham School of Optometry, Clinical Eye Research Center Birmingham Alabama 35294 —
Trinity Research Group Dothan Alabama 36301 —
Cornea and Cataract Consultants of Arizona Phoenix Arizona 85032 —
Citrus Valley Eyecare / Premiere Practice Management, LLC Covina California 91723 —
Orange County Ophthalmology Medical Group Garden Grove California 92843 —
Global Research Management Glendale California 91204 —
Inland Eye Specialists Hemet California 92545 —
United Medical Research Institute Inglewood California 90301 —
Premiere Practice Management, LLC Los Angeles California 90013 —
North Valley Eye Medical Group, Inc Mission Hills California 91345 —
LoBue Laser and Eye Medical Center Murrieta California 92562 —
Eye Research Foundation, Inc. Newport Beach California 92663 —
Pendleton Eye Center Oceanside California 92056 —
Martel Eye Medical Group Rancho Cordova California 95670 —
Sierra Clinical Trial Research Organization Santa Ana California 92705 —
Premiere Practice Management, LLC Torrance California 90505 —
Wolstan and Goldberg Eye Associates Torrance California 90505 —
Vision Institute Colorado Springs Colorado 80907 —
Corneal Consultants of Colorado dba Colorado Eye Consultants Littleton Colorado 80120 —
Segal Drug Trials Delray Beach Florida 33484 —
Bowden Eye & Associates Jacksonville Florida 32256 —
Shettle Eye Research, Inc. Largo Florida 33773 —
International Research Center Tampa Florida 33603 —
Dixophthal, PC. Albany Georgia 31701 —
Edwin Yoshio Endo, OD & Associates & Interns ‘Aiea Hawaii 96701 —
Chicago Cornea Consultants Hoffman Estates Illinois 60169 —
Jones Eye Clinic and Surgery Center Sioux City Iowa 51104 —
Seidenberg Protzko Eye Associates Havre de Grace Maryland 21078 —
Midwest Vision Research Foundation at Pepose Vision Institute Chesterfield Missouri 63017 —
Tauber Eye Center Kansas City Missouri 64111 —
Tekwani Vision Center St Louis Missouri 63128 —
Ophthalmology Associates St Louis Missouri 63131 —
Comprehensive Eye Care, Ltd. Washington Missouri 63090 —
Wellish Vision Institute Las Vegas Nevada 89119 —
Asheville Eye Associates Asheville North Carolina 28803 —
Oculus Research Garner North Carolina 27529 —
Wake Forest Health Network, LLC High Point North Carolina 27262 —
Insight Research Clinic, LLC dba EyeCare Professionals Powell Ohio 43065 —
Conestoga Eye PC Lancaster Pennsylvania 17601 —
Associates in Ophthalmology Ltd West Mifflin Pennsylvania 15122 —
West Bay Eye Associates Warwick Rhode Island 02888 —
Total Eye Care, PA Memphis Tennessee 38119 —
Advancing Vision Research Smyrna Tennessee 37167 —
Keystone Research Austin Texas 78731 —
Hill Country Eye Center Cedar Park Texas 78613 —
Southwest Eye Institute El Paso Texas 79902 —
Lake Travis Eye and Laser Center/Revolution Research Lakeway Texas 78738 —
R and R Eye Research, LLC San Antonio Texas 78229 —
DCT-Shah Research, LLC dba Discovery Clinical Trials San Antonio Texas 78230 —
Northern Virginia Ophthalmology Associates Falls Church Virginia 22042 —
Virginia Eye Consultants, Inc. Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05403827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2025 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05403827 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →